| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 07/15/2024 |
3. Issuer Name and Ticker or Trading Symbol
HOME BANCORP, INC. [ HBCP ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock | 5,509 | D(1)(2)(3)(4)(5) | |
| Common Stock | 1,254.0259 | I | 401K Plan |
| Common Stock | 6,311.4072 | I | ESOP |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Employee Stock Option (Right to Buy) | (6) | 05/12/2025 | Common Stock | 520 | $22.25 | D | |
| Employee Stock Option (Right to Buy) | (7) | 05/23/2026 | Common Stock | 660 | $28 | D | |
| Employee Stock Option (Right to Buy) | (8) | 05/12/2027 | Common Stock | 750 | $35.26 | D | |
| Employee Stock Option (Right to Buy) | (9) | 05/23/2028 | Common Stock | 740 | $45.12 | D | |
| Employee Stock Option (Right to Buy) | (10) | 05/23/2029 | Common Stock | 850 | $35.85 | D | |
| Employee Stock Option (Right to Buy) | (11) | 03/12/2030 | Common Stock | 800 | $21.99 | D | |
| Employee Stock Option (Right to Buy) | (12) | 05/12/2031 | Common Stock | 1,000 | $36.77 | D | |
| Explanation of Responses: |
| 1. Includes the grant of 1400 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2024, and that may be settled only in shares of the Issuer's common stock. As of the date of this filing, 1,120 restricted stock units remain unvested. |
| 2. Includes the grant of 1600 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2025, and that may be settled only in shares of the Issuer's common stock. |
| 3. Includes the grant of 300 restricted stock units pursuant to the Issuer's 2014 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on March 12, 2021, and that may be settled only in shares of the Issuer's common stock. As of the date of this filing, 60 restricted stock units remain unvested. |
| 4. Includes the grant of 425 restricted stock units pursuant to the Issuer's 2014 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2022, and that may be settled only in shares of the Issuer's common stock. As of the date of this filing, 170 restricted stock units remain unvested. |
| 5. Includes the grant of 975 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2023, and that may be settled only in shares of the Issuer's common stock. As of the date of this filing, 585 restricted stock units remain unvested. |
| 6. The options vest and become exercisable in five equal installments beginning May 12, 2016. As of the date of this filing 520 options remain unexercised. |
| 7. The options vest and become exercisable in five equal installments beginning May 23, 2017. As of the date of this filing 660 options remain unexercised. |
| 8. The options vest and become exercisable in five equal installments beginning May 12, 2018. |
| 9. The options vest and become exercisable in five equal installments beginning May 23, 2019. |
| 10. The options vest and become exercisable in five equal installments beginning May 23, 2020. |
| 11. The options vest and become exercisable in five equal installments beginning March 12, 2021. |
| 12. The options vest and become exercisable in five equal installments beginning May 12, 2022. |
| /s/ John J. Zollinger, IV | 07/24/2024 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||